🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The challenge of LDLT to HCC is that tumors with a high risk of recurrence ...
Status
Recruiting
Location
Department of Surgery
Start Date
2021-04-01
Trial ID
NCT06327269
Treatments Being Tested
This will be a randomized, single-dose, open-label, two-period crossover st...
Status
Completed
Location
Charles River Clinical Studies, NW
Start Date
2010-07
Trial ID
NCT01240408
AMBER is a multicentre, single-arm phase II trial. The protocol treatment c...
Status
Withdrawn
Location
Medical University of Innsbruck / UK für Innere Medizin V
Start Date
2025-03
Trial ID
NCT06068153
Treatments Being Tested
This study will compare the efficacy and safety of belzutifan + lenvatinib ...
Status
Active Not Recruiting
Location
Ironwood Cancer & Research Centers ( Site 0077)
Start Date
2021-02-25
Trial ID
NCT04586231
Treatments Being Tested
This Expanded Access Program (EAP) consists of a Prerandomization Phase and...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT02211222
Treatments Being Tested
This will be a randomized, single dose, open-label, three-treatment period ...
Status
Completed
Location
Multiple Locations
Start Date
2013-07
Trial ID
NCT02723630
Treatments Being Tested
This study will evaluate the efficacy and safety of pembrolizumab (MK-3475)...
Status
Completed
Location
Comprehensive Blood & Cancer Center [Bakersfield, CA] ( Site 1604)
Start Date
2019-06-26
Trial ID
NCT03976375
Treatments Being Tested
This is a Phase 2 trial Safety Lead-in trial conducted in 3 cohorts of pati...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08
Trial ID
NCT05106127
Treatments Being Tested
This is a single-arm, multicenter, Phase 2 study of lenvatinib in combinati...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2017-02-20
Trial ID
NCT02915783
Treatments Being Tested
This prospective, single-arm study was aimed to evaluate the efficacy of re...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-03-30
Trial ID
NCT06253598
Treatments Being Tested